ATRi Transition Rollover Study
The main purpose of the study was to monitor the safety of participant receiving long-term treatment of Berzosertib as monotherapy.
Advanced Stage Solid Tumors
DRUG: Berzosertib
Number of Participants With Adverse Events (AEs) and Treatment Related AEs, An AE is any untoward medical occurrence in a participant or clinical investigation participant administered a pharmaceutical product, regardless of causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. Treatment-related AEs: reasonably related to the study intervention., Up to 6 years
The main purpose of the study was to monitor the safety of participant receiving long-term treatment of Berzosertib as monotherapy.